On May 19, 2021 Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, reported that it will participate in Noble Capital Markets’ Virtual Roadshow Series, presented by Channelchek on May 20, 2021 (Press release, Genprex, MAY 19, 2021, View Source [SID1234580298]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The virtual roadshow will feature a corporate presentation from Genprex’s President and Chief Executive Officer, Rodney Varner, followed by a Q & A session proctored by Noble Senior Research Analyst, Robert LeBoyer. Registration is free and open to all investors, at any level.

Noble Capital Markets’ Virtual Roadshow Series
Presentation Date: May 20, 2021
Presentation Time: 1-2 p.m. EDT
Registration Link: https://bit.ly/3hyiXcs

Noble’s research, as well as news and advanced market data on Genprex is available on Channelchek.com.